Document is current

Any future updates will be listed below

Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study

Crossref DOI link: https://doi.org/10.1007/s12185-021-03231-6

Published Online: 2021-10-06

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark